Public Policy
CEO and cofounder Lori Evans Bernstein explains why Caraway is focused on women and people assigned female at birth and discusses the startup's strategy for offering reproductive healthcare in states where abortion access is restricted.
The Israeli startup said it's now focused on receiving clearance to use its AEYE-DS system with a portable camera.
Elizabeth Holmes, founder of the scandal-ridden blood-testing startup, was found guilty on four of eleven charges in January.
Ochsner Health Chief Digital Officer Dr. Denise Basow discusses the health system's remote monitoring pilot program for Medicaid patients with chronic conditions like hypertension and Type 2 diabetes.
The analysis found mean daily requests for abortion medications provided through Aid Access were 82.6 during the baseline period. They reached 213.7 after the Supreme Court decision overturning Roe v. Wade was announced.
When determining approval for Breakthrough Device designation, the FDA will consider whether the device addresses present health inequities.
David Rosen, a partner and public policy lawyer at Foley & Lardner, discusses the agency's recently wrapped Software Precertification Pilot Program and what it means for the future of digital health regulation.
From hospital closures to physician shortages, provider scarcity is a big challenge when it comes to expanding Medicare Advantage in rural communities.
The company announced a $10 million Series B raise last year.
The company said the clearance will allow more pharma companies to use Tasso+ for decentralized clinical trials.